Characterization of the activity of KTX-1001, a small molecule inhibitor of multiple myeloma SET domain using surface plasmon resonance
- Journal:
- Journal of Biological Chemistry
- Published:
- Affiliations:
- 3
- Authors:
- 4
| Institutions | Authors | Share |
|---|---|---|
| K36 Therapeutics, United States of America (USA) | 0.50 | |
| Reaction Biology Corporation (RBC), United States of America (USA) | 0.25 | |
| BB Preclinical Consulting, United States of America (USA) | 0.25 |